Viridien
Short position disclosed on September 22, 2026.
8.39% of the capital sold short
9 disclosing funds
2,491 disclosures on record
Evolution of the disclosed total
0%2.5%5%7.5%10%
Oct 2025Jan 2026Apr 2026Jul 2026
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Capital Fund Management | 1.52% | +0.95 pt | September 15, 2026 | ||
| Marshall Wace LLP | 1.40% | -0.11 pt | September 22, 2026 | ||
| Citadel Advisors LLC | 1.12% | +0.34 pt | September 21, 2026 | ||
| Worldquant, LLC | 1.03% | new | September 22, 2026 | ||
| Walleye Capital LLC | 0.71% | new | August 17, 2026 | AMF | |
| TWO Sigma Investments, LP | 0.70% | new | August 19, 2026 | AMF | |
| Tudor Capital Europe LLP | 0.70% | new | September 21, 2026 | ||
| Acadian Asset Management LLC | 0.64% | new | September 22, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 7,682 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| July 3, 2023 | Qube Research & Technologies Limited | 1.20% | March 4, 2024 | |
| July 3, 2023 | Citadel Advisors LLC | 0.36% | July 5, 2023 | |
| June 30, 2023 | Marshall Wace LLP | 1.99% | August 15, 2023 | |
| June 29, 2023 | Qube Research & Technologies Limited | 1.05% | March 4, 2024 | |
| June 29, 2023 | Systematica Investments Limited | 0.80% | August 14, 2023 | |
| June 29, 2023 | Citadel Advisors LLC | 0.57% | July 5, 2023 | |
| June 27, 2023 | Qube Research & Technologies Limited | 0.97% | March 4, 2024 | |
| June 27, 2023 | Citadel Advisors LLC | 0.68% | July 5, 2023 | |
| June 26, 2023 | Qube Research & Technologies Limited | 1.01% | March 4, 2024 | |
| June 23, 2023 | Qube Research & Technologies Limited | 1.15% | March 4, 2024 | |
| June 23, 2023 | Systematica Investments Limited | 0.72% | August 14, 2023 | |
| June 22, 2023 | Qube Research & Technologies Limited | 1.09% | March 4, 2024 | |
| June 20, 2023 | Citadel Advisors LLC | 0.78% | July 5, 2023 | |
| June 19, 2023 | Qube Research & Technologies Limited | 1.12% | March 4, 2024 | |
| June 16, 2023 | Qube Research & Technologies Limited | 1.07% | March 4, 2024 | |
| June 16, 2023 | Hrteu Limited | 0.50% | August 16, 2023 | |
| June 15, 2023 | Qube Research & Technologies Limited | 1.11% | March 4, 2024 | |
| June 15, 2023 | Systematica Investments Limited | 0.60% | August 14, 2023 | |
| June 14, 2023 | Marshall Wace LLP | 2.03% | August 15, 2023 | |
| June 14, 2023 | Citadel Advisors LLC | 0.80% | July 5, 2023 | |
| June 12, 2023 | Citadel Advisors LLC | 0.74% | July 5, 2023 | |
| June 9, 2023 | Qube Research & Technologies Limited | 1.04% | March 4, 2024 | |
| June 9, 2023 | Systematica Investments Limited | 0.51% | August 14, 2023 | |
| June 7, 2023 | Citadel Advisors LLC | 0.68% | July 5, 2023 | |
| June 6, 2023 | Marshall Wace LLP | 1.99% | August 15, 2023 | |
| June 6, 2023 | Citadel Advisors LLC | 0.80% | July 5, 2023 | |
| June 5, 2023 | Qube Research & Technologies Limited | 1.12% | March 4, 2024 | |
| June 2, 2023 | Marshall Wace LLP | 2.03% | August 15, 2023 | |
| June 2, 2023 | Qube Research & Technologies Limited | 1.08% | March 4, 2024 | |
| May 31, 2023 | Marshall Wace LLP | 2.25% | August 15, 2023 | |
| May 31, 2023 | Citadel Advisors LLC | 0.79% | July 5, 2023 | |
| May 30, 2023 | Citadel Advisors LLC | 0.90% | July 5, 2023 | |
| May 26, 2023 | Qube Research & Technologies Limited | 0.99% | March 4, 2024 | |
| May 25, 2023 | Qube Research & Technologies Limited | 1.00% | March 4, 2024 | |
| May 25, 2023 | Citadel Advisors LLC | 0.89% | July 5, 2023 | |
| May 23, 2023 | Qube Research & Technologies Limited | 0.97% | March 4, 2024 | |
| May 23, 2023 | Citadel Advisors LLC | 0.88% | July 5, 2023 | |
| May 19, 2023 | Qube Research & Technologies Limited | 1.08% | March 4, 2024 | |
| May 18, 2023 | Qube Research & Technologies Limited | 1.16% | March 4, 2024 | |
| May 16, 2023 | Marshall Wace LLP | 2.37% | August 15, 2023 | |
| May 15, 2023 | Qube Research & Technologies Limited | 1.21% | March 4, 2024 | |
| May 12, 2023 | Marshall Wace LLP | 2.40% | August 15, 2023 | |
| May 12, 2023 | Qube Research & Technologies Limited | 1.18% | March 4, 2024 | |
| May 8, 2023 | Citadel Advisors LLC | 0.97% | July 5, 2023 | |
| May 5, 2023 | Qube Research & Technologies Limited | 1.21% | March 4, 2024 | |
| May 5, 2023 | Citadel Advisors LLC | 1.00% | July 5, 2023 | |
| May 4, 2023 | Qube Research & Technologies Limited | 1.12% | March 4, 2024 | |
| May 4, 2023 | Citadel Advisors LLC | 0.95% | July 5, 2023 | |
| May 3, 2023 | Qube Research & Technologies Limited | 0.91% | March 4, 2024 | |
| May 2, 2023 | Qube Research & Technologies Limited | 0.87% | March 4, 2024 |
The AMF column opens the filing the fund itself lodged, on the regulator own site.
Download 2491 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.35% of the capital sold short
- Valeo 11.29% of the capital sold short
- Renault 9.50% of the capital sold short
- Teleperformance 6.31% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Alstom 4.57% of the capital sold short
- Elis 4.57% of the capital sold short
- Abivax 4.47% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- DBV Technologies 4.21% of the capital sold short
- VusionGroup 3.91% of the capital sold short
- Sopra Steria Group 3.90% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at September 22, 2026, https://www.quivad.com/action/viridien?page=14